Collapse
μ-Opioid receptor agonists (opioids ) (e.g., morphine , heroin , hydrocodone , oxycodone , opium , kratom )α2 δ subunit -containing voltage-dependent calcium channels blockers (gabapentinoids ) (e.g., gabapentin , pregabalin , phenibut )AMPA receptor antagonists (e.g., perampanel )CB1 receptor agonists (cannabinoids ) (e.g., THC , cannabis )Dopamine receptor agonists (e.g., levodopa )Dopamine releasing agents (e.g., amphetamine , methamphetamine , MDMA , mephedrone )Dopamine reuptake inhibitors (e.g., cocaine , methylphenidate )GABAA receptor positive allosteric modulators (e.g., barbiturates , benzodiazepines , carbamates , ethanol (alcohol) (alcoholic drink ), inhalants , nonbenzodiazepines , quinazolinones )GHB (sodium oxybate ) and analogues Glucocorticoids (corticosteroids) (e.g., dexamethasone , prednisone )nACh receptor agonists (e.g., nicotine , tobacco , arecoline , areca nut )Nitric oxide prodrugs (e.g., alkyl nitrites (poppers ))NMDA receptor antagonists (e.g., DXM , ketamine , methoxetamine , nitrous oxide , phencyclidine , inhalants )Orexin receptor antagonists (e.g., suvorexant )
Initial visibility: autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed: {{Euphoriants|state=collapsed}} to show the template collapsed, i.e., hidden apart from its title bar|state=expanded: {{Euphoriants|state=expanded}} to show the template expanded, i.e., fully visible|state=autocollapse: {{Euphoriants|state=autocollapse}}
shows the template collapsed to the title bar if there is a {{navbox }} , a {{sidebar }} , or some other table on the page with the collapsible attribute
shows the template in its expanded state if there are no other collapsible items on the page
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse